Product Offerings
Products:
Veterinary Active Pharmaceutical Ingredients (APIs): Oxytetracycline, Tylosin, Enrofloxacin
Veterinary Formulations: Antibiotics, Anthelmintics, Anti-inflammatory drugs
Siflon Drugs is a specialized manufacturer and exporter of veterinary pharmaceutical products based in Hyderabad, India. Established with a mission to contribute to global animal health, the company has built a strong presence in the international veterinary API and formulation markets, backed by quality compliance, robust R&D, and customer-centric practices.
Core Business
Siflon Drugs focuses exclusively on the development, production, and export of veterinary Active Pharmaceutical Ingredients (APIs) and formulated veterinary drugs. The company caters to global markets by providing high-quality, cost-effective pharmaceutical products for livestock, poultry, and aquaculture industries.
Their product line includes essential categories such as antibiotics, anti-inflammatory drugs, and anthelmintics, which are vital for disease prevention and productivity enhancement in animals.
Product and Service Offerings
Siflon Drugs manufactures and supplies a comprehensive range of veterinary APIs and finished formulations. Key offerings include:
-
Veterinary APIs:
- Oxytetracycline
- Tylosin
- Enrofloxacin
-
Veterinary Formulations:
- Antibiotic combinations for bacterial infections
- Anthelmintic drugs for deworming
- Anti-inflammatory products to manage inflammation and pain in animals
These products are available in multiple dosage forms and strengths as per international pharmacopeial standards.
Specialization and Core USP
Siflon Drugs specializes in veterinary-only APIs and formulations, setting it apart from companies that also manufacture human drugs. This singular focus allows Siflon to maintain high standards of efficacy, safety, and regulatory compliance specifically for animal health applications.
The company emphasizes:
- In-house R&D for continuous product development and improvement.
- GMP-compliant facilities adhering to stringent manufacturing protocols.
- Customized product solutions and contract manufacturing capabilities.
Financial Strength and Business Scale
While Siflon Drugs is a privately owned enterprise and does not publicly disclose its financials, its long-standing presence and consistent participation in global export markets suggest a stable business model with recurring revenue streams. The company's ability to maintain multi-country exports over years further reinforces its financial reliability and operational scale.
Shipment Data
According to global import-export tracking platforms such as ImportYeti and Volza, Siflon Drugs has an established export footprint. Key highlights include:
- Active Export Regions: Southeast Asia, Africa, Latin America, and Middle East.
- Top Exported Products: Oxytetracycline API and Tylosin.
- Shipping Frequency: Regular consignments to major distributors and veterinary pharmaceutical companies.
These exports are typically carried out in bulk packaging, suggesting B2B business with veterinary pharma manufacturers and large distributors.
Target Market
Siflon Drugs caters to a global clientele including:
- Veterinary pharmaceutical manufacturers
- Animal health distributors and importers
- Government veterinary procurement agencies
- Contract research and manufacturing organizations (CRAMs)
Their focus remains on businesses that require reliable veterinary APIs and custom formulation partners for volume-based procurement.
Capabilities
- State-of-the-art manufacturing plant located in Andhra Pradesh
- GMP and Schedule M compliant production
- Analytical lab for quality control and batch consistency
- Custom formulation and contract manufacturing services
- Regulatory support for documentation and compliance
Certifications and Compliance
Siflon Drugs operates under the regulatory framework of the Drugs Control Administration of India and holds certifications that align with WHO-GMP and Schedule M guidelines, ensuring manufacturing quality and safety.
The company’s operations are also aligned with international pharmacopeias such as USP, BP, and IP, making its products compliant for export markets.
Customer Testimonials
While direct testimonials are limited on public platforms, consistent international purchases and returning clients in regions like Africa and Southeast Asia are strong indicators of customer satisfaction. Repeat exports to the same countries confirm trust and dependability in both product quality and service.
Major Achievements
- Long-standing presence in over 15 export countries
- Expanded veterinary API manufacturing capacity over the past decade
- Publication of detailed product brochures for client transparency
- Recognized for reliable contract manufacturing and third-party supply services
Siflon Drugs continues to solidify its position in the global veterinary pharmaceutical landscape through its commitment to quality, compliance, and customer-centric manufacturing. Their ability to deliver essential veterinary drugs efficiently and at competitive pricing makes them a trusted partner in animal healthcare.